Sun Young Kim

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Economic evaluation of pneumococcal conjugate vaccination in The Gambia
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Center for Health Decision Science, Boston, MA, USA
    BMC Infect Dis 10:260. 2010
  2. ncbi Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam
    Sun Young Kim
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    Med Decis Making 30:E1-E28. 2010
  3. ncbi Health and economic impact of rotavirus vaccination in GAVI-eligible countries
    Sun Young Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 10:253. 2010
  4. ncbi Cost-effectiveness of Rotavirus vaccination in Vietnam
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 9:29. 2009
  5. ncbi Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Reprod Health Matters 16:86-96. 2008
  6. ncbi Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches
    Sun Young Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Pharmacoeconomics 26:191-215. 2008
  7. ncbi Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden
    Sun Young Kim
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    BMC Infect Dis 11:174. 2011
  8. ncbi Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 30:498-506. 2006
  9. ncbi Mathematical models of cervical cancer prevention in the Asia Pacific region
    Sue J Goldie
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Vaccine 26:M17-29. 2008
  10. ncbi Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
    Sun Young Kim
    Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
    Bull World Health Organ 85:833-42. 2007

Detail Information

Publications13

  1. ncbi Economic evaluation of pneumococcal conjugate vaccination in The Gambia
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Center for Health Decision Science, Boston, MA, USA
    BMC Infect Dis 10:260. 2010
    ..Our objective was to assess the potential impact of PCVs of different valences in The Gambia...
  2. ncbi Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam
    Sun Young Kim
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    Med Decis Making 30:E1-E28. 2010
    ....
  3. ncbi Health and economic impact of rotavirus vaccination in GAVI-eligible countries
    Sun Young Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 10:253. 2010
    ..Our objective was to provide information on the expected health, economic and financial consequences of rotavirus vaccines in the 72 GAVI support-eligible countries...
  4. ncbi Cost-effectiveness of Rotavirus vaccination in Vietnam
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 9:29. 2009
    ..g., the possibility of reinfection and varying degrees of partial immunity conferred by natural infection), and assess the influence of the features on the cost-effectiveness of rotavirus vaccination...
  5. ncbi Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Reprod Health Matters 16:86-96. 2008
    ..Concerns about financial costs and affordability highlight the need for lowering vaccine prices, cost-efficient mechanisms for delivery of vaccinations to adolescents, and creative sources of financing...
  6. ncbi Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches
    Sun Young Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Pharmacoeconomics 26:191-215. 2008
    ..Our results emphasize the need to improve modelling methods for CEAs of vaccination programmes; specifically, model choice, construction, assessment and validation...
  7. ncbi Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden
    Sun Young Kim
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    BMC Infect Dis 11:174. 2011
    ..The purpose of this study is to provide early insight into how the comparative impact of different new vaccines could be assessed in resource-poor settings with respect to affordability, cost-effectiveness, and distributional equity...
  8. ncbi Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Am J Prev Med 30:498-506. 2006
    ....
  9. ncbi Mathematical models of cervical cancer prevention in the Asia Pacific region
    Sue J Goldie
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Vaccine 26:M17-29. 2008
    ....
  10. ncbi Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
    Sun Young Kim
    Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
    Bull World Health Organ 85:833-42. 2007
    ..We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia...
  11. ncbi Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
    Sue J Goldie
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    Vaccine 26:4080-93. 2008
    ....
  12. ncbi Mathematical models of cervical cancer prevention in Latin America and the Caribbean
    Sue J Goldie
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Vaccine 26:L59-72. 2008
    ..If the cost per vaccinated girl is less than I$25 HPV-16/18 vaccination would be very cost-effective in all 33 countries; for it to be affordable, costs may need to be lower...
  13. ncbi Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience
    Sun Young Kim
    Center for Health Decision Science, Department of Health Policy and Managemnt, Harvard School of Public Health, Boston, MA, USA
    S Afr Med J 101:659-64. 2011
    ..To contain ongoing cholera outbreaks, the World Health Organization has suggested that reactive vaccination should be considered in addition to its previous control measures...